TOP2A and cervical carcinoma: Our study not only provides single-cell and experimental evidence for the treatment of cervical cancer with FOXM1, but also suggests that there may be a potential connection between FOXM1 and TOP2A, but this hypothesis still needs to be verified experimentally (75).